Celestra Inc
352770
Company Profile
Business description
Celestra Inc is a biotechnology company. The company provides early diagnosis of cancer/diseases based on genome and pursues to overcome aging and diseases through liquid biopsy and Multi-Omics technology. It offers a genome-based, early cancer diagnostic service through technology for multi-omics analysis and simultaneous detection of CTC and cfDNA in the blood based.
Contact
Building 110, UNIST, 50
Suite 301-3, UNIST-gil, Eonyang-eup, Ulju-gun
Ulsan44919
KORT: +82 7082866966
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
48
Stocks News & Analysis
stocks
Are small caps finally back?
Does renewed investor interest point to a structural shift in the underperforming factor?
stocks
Chart of the Week: Modest earnings growth at odds with overvalued bank shares
The latest update from our Industry Pulse report.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,329.10 | 50.90 | 0.55% |
CAC 40 | 8,236.73 | 29.86 | 0.36% |
DAX 40 | 24,101.93 | 49.20 | -0.20% |
Dow JONES (US) | 46,590.41 | 334.33 | -0.71% |
FTSE 100 | 9,571.61 | 56.61 | 0.59% |
HKSE | 25,967.98 | 186.21 | 0.72% |
NASDAQ | 22,740.40 | 213.27 | -0.93% |
Nikkei 225 | 48,641.61 | 666.18 | -1.35% |
NZX 50 Index | 13,377.10 | 70.66 | 0.53% |
S&P 500 | 6,699.40 | 0.00 | 0.00% |
S&P/ASX 200 | 9,032.80 | 46.60 | 0.52% |
SSE Composite Index | 3,922.41 | 8.65 | 0.22% |